| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 163 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 155 |
| 2 | TACROLIMUS OINTMENT 0.1% | 155 |
| 3 | PREDNISONE | 134 |
| 4 | FUROSEMIDE | 108 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 84 |
| 6 | MYCOPHENOLATE MOFETIL | 83 |
| 7 | METOPROLOL TARTRATE | 70 |
| 8 | METOPROLOL | 67 |
| 9 | BISOPROLOL FUMARATE | 65 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLURBIPROFEN | 15 | 0.0098 |
| 1 | DOPAMINE HYDROCHLORIDE | 33 | 0.0087 |
| 2 | CAFFEINE CITRATE | 11 | 0.0047 |
| 3 | NITRIC OXIDE | 16 | 0.0035 |
| 4 | GOLD | 14 | 0.0024 |
| 5 | AGALSIDASE BETA | 19 | 0.0020 |
| 6 | SIROLIMUS | 22 | 0.0016 |
| 7 | DESLORATADINE | 16 | 0.0015 |
| 8 | TACROLIMUS OINTMENT 0.1% | 155 | 0.0012 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 155 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 311 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 136 |
| 2 | Loop Diuretic [EPC] | 126 |
| 3 | Benzodiazepine [EPC] | 106 |
| 4 | Proton Pump Inhibitor [EPC] | 77 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 71 |
| 6 | beta-Adrenergic Blocker [EPC] | 70 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 60 |
| 8 | Aldosterone Antagonist [EPC] | 58 |
| 9 | Calcium Channel Blocker [EPC] | 57 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Medium-chain Triglyceride [EPC] | 3 | 0.0054 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 20 | 0.0021 |
| 2 | Surfactant [EPC] | 2 | 0.0017 |
| 3 | alpha-Hydroxy Acid [EPC] | 3 | 0.0014 |
| 4 | Cardiac Myosin Inhibitor [EPC] | 8 | 0.0013 |
| 5 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 4 | 0.0012 |
| 6 | alpha-1 Adrenergic Agonist [EPC] | 5 | 0.0011 |
| 7 | Recombinant Human Growth Hormone [EPC] | 24 | 0.0011 |
| 8 | Carnitine Analog [EPC] | 3 | 0.0008 |
| 9 | Provitamin D2 Compound [EPC] | 23 | 0.0008 |